>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

LNN +9.7%, PRGS +6.6%, (also acquires Kinvay a privately-held company based in Boston and leader in Backend as a Service (BaaS) technology, for $49 mln in cash), STZ +5.4%, WOR +3.7%, GBX +2.6%,IRET +2.5%, GMS +2.5%, MKC +2%, KLIC +1.7%, SHLM +0.7%, CAG +0.5%

M&A news:

MBUU +7.6% (Malibu Boats to acquire Cobalt Boats for aggregate purchase price of $130 mln; expected to be accretive to Malibu's EPS; will host a conference call June 29 at 8:30 am ET)
WBA +5.1% (Rite Aid (RAD) and Walgreens terminate merger, sign new agreement whereby Walgreens will acquire 2,186 stores, related distribution assets and inventory from Rite Aid for an all-cash purchase price of $5.175 bln; also reported earnings)
SPLS +1.7% (Staples confirms definitive agreement to be acquired by Sycamore Partners for $10.25 per share in cash, or approximately $6.9 bln)

Select financial related names showing strength following CCAR results:

HSBC +4.8%, C +3.5%, JPM +3%, RF +2.9%, KEY +2.8%, BAC +2.8%,ZION +2.8%, HBAN +2.8%, DB +2.7%, DFS +2.7%, PNC +2.5%, MS+2.4%, BK +2.4%, STI +2.2%, GS +2.1%, CMA +2%, USB +2%, FITB +2%,WFC +1.8%, STT +1.7%, AXP +1.5%, BBVA +1.4%, SAN +1.2%, CFG+1.2%, MTB +1.1%, ALLY +1%, .

Other news:

SPEX +40.3% (continued momentum)
TROV +29.2% (executes supplier agreement with NerPharMa in Milan, Italy, to manufacture drug product for PCM-075)
NXTD +11.4% (continued strength; also Nxt-ID's Fit Pay is now providing payment capabilities for Token, a biometric identity ring that streamlines authentication process), GEMP +10% (announces top-line data on the LDL-C primary endpoint from the completed open label Phase 2b COBALT-1 trial; Gemcabene achieves primary endpoint for LDL cholesterol in phase 2b HoFH trial)
WATT +7.1% (Dialog Semiconductor invests additional $15 million in Energous Corporation)
OMER +6.4% (Omeros states it is 'aware of a report posted on-line' by Art Doyle; defends itself against allegations)
SRPT +4% (appoints Douglas S. Ingram as president and CEO)
VRX +3.6% (Salix announced FDA accepted the New Drug Application for NER1006 (PLENVU); expects FDA decision in first-quarter 2018)
NTNX +2.6% (extending this afternoon's move higher; confirms .NEXT Conference updates)
LULU +2.2% (Director/co-Chair Glenn Murphy disclosed purchase of 100K shares worth more than $5.5 mln)

Analyst comments: